{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:25:52Z","timestamp":1774581952136,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jacadv.2025.101859","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T19:40:13Z","timestamp":1749238813000},"page":"101859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pro-C-Type Natriuretic Peptide in Women With Angina Pectoris and No Obstructive Coronary Artery Disease"],"prefix":"10.1016","volume":"4","author":[{"given":"Peter D.","family":"Mark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Schroder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas K.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9684-5096","authenticated-orcid":false,"given":"Timothy C.R.","family":"Prickett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4134-0349","authenticated-orcid":false,"given":"Eva","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens P.","family":"Goetze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jacadv.2025.101859_bib1","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen","year":"2012","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.jacadv.2025.101859_bib2","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.2014.14681","article-title":"Nonobstructive coronary artery disease and risk of myocardial infarction","volume":"312","author":"Maddox","year":"2014","journal-title":"JAMA - J Am Med Assoc"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101859_bib3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archinternmed.2009.50","article-title":"Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the women\u2019s ischemia syndrome evaluation study and the St James Women Take Heart Project","volume":"169","author":"Gulati","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacadv.2025.101859_bib4","article-title":"Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction","volume":"24","author":"Schroder","year":"2019","journal-title":"IJC Hear Vasc"},{"issue":"4","key":"10.1016\/j.jacadv.2025.101859_bib5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.numecd.2013.09.021","article-title":"Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease","volume":"24","author":"Tona","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacadv.2025.101859_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100264","article-title":"Biomarkers and coronary microvascular dysfunction in women with angina and No obstructive coronary artery disease","volume":"2","author":"Prescott","year":"2023","journal-title":"JACC Adv"},{"issue":"11","key":"10.1016\/j.jacadv.2025.101859_bib7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","article-title":"Ischemia and No obstructive coronary artery disease (INOCA): developing evidence-based therapies and Research agenda for the next decade","volume":"135","author":"Noel Bairey Merz","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacadv.2025.101859_bib8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/CIRCULATIONAHA.117.033383","article-title":"Endothelial C-type natriuretic peptide acts on pericytes to regulate microcirculatory flow and blood pressure","volume":"138","author":"\u0160piranec","year":"2018","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.jacadv.2025.101859_bib9","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.118.036344","article-title":"Endothelial C-type natriuretic peptide is a critical regulator of angiogenesis and vascular remodeling","volume":"139","author":"Bubb","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101859_bib10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/HYPERTENSIONAHA.116.08219","article-title":"Endothelium-derived C-type natriuretic peptide contributes to blood pressure regulation by maintaining endothelial integrity","volume":"69","author":"Nakao","year":"2017","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101859_bib11","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1172\/JCI74281","article-title":"Endothelial C-type natriuretic peptide maintains vascular homeostasis","volume":"124","author":"Moyes","year":"2014","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101859_bib12","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/eurheartj\/ehz093","article-title":"C-type natriuretic peptide co-ordinates cardiac structure and function","volume":"41","author":"Moyes","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101859_bib13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1373\/clinchem.2016.257816","article-title":"C-type natriuretic peptides in coronary disease","volume":"63","author":"Prickett","year":"2017","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101859_bib14","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/ejhf.140","article-title":"Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction","volume":"16","author":"Lok","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101859_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jchf.2021.04.013","article-title":"Prognostic value of urinary and plasma C-type natriuretic peptide in acute decompensated heart failure","volume":"9","author":"Ma","year":"2021","journal-title":"JACC Heart Fail"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101859_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048312","article-title":"Sex-specific mortality prediction by pro-C-type natriuretic peptide measurement in a prospective cohort of patients with ST-elevation myocardial infarction","volume":"11","author":"Mark","year":"2021","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.jacadv.2025.101859_bib17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ahj.2014.01.003","article-title":"Improving diagnosis and treatment of women with angina pectoris and microvascular disease: the iPOWER study design and rationale","volume":"167","author":"Prescott","year":"2014","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101859_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/eurheartj\/ehaa944","article-title":"Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study","volume":"42","author":"Schroder","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2025.101859_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.02.005","article-title":"Peripheral reactive hyperemia index and coronary microvas-cular function in women with no obstructive CAD: the iPOWER study","volume":"9","author":"Michelsen","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101859_bib20","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1161\/HYPERTENSIONAHA.115.05366","article-title":"Circulating C-type natriuretic peptide and its relationship to cardiovascular disease in the general population","volume":"65","author":"Sangaralingham","year":"2015","journal-title":"Hypertension"},{"issue":"1-2","key":"10.1016\/j.jacadv.2025.101859_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jim.2010.08.003","article-title":"Processing-independent analysis for pro-C-type natriuretic peptide","volume":"362","author":"Lippert","year":"2010","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101859_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1566524033361717","article-title":"The posttranslational phase of gene expression: new possibilities in molecular diagnosis","volume":"3","author":"Rehfeld","year":"2005","journal-title":"Curr Mol Med"},{"issue":"4","key":"10.1016\/j.jacadv.2025.101859_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101859_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0169-7439(01)00155-1","article-title":"PLS-regression: a basic tool of chemometrics","volume":"58","author":"Wold","year":"2001","journal-title":"Chemom Intell Lab Syst"},{"issue":"11","key":"10.1016\/j.jacadv.2025.101859_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i11","article-title":"Feature selection with the Boruta package","volume":"36","author":"Kursa","year":"2010","journal-title":"J Stat Softw"},{"issue":"5","key":"10.1016\/j.jacadv.2025.101859_bib26","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/cen.12035","article-title":"Impact of age, phenotype and cardio-renal function on plasma C-type and B-type natriuretic peptide forms in an adult population","volume":"78","author":"Prickett","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101859_bib28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1373\/clinchem.2017.280354","article-title":"New insights into cardiac and vascular natriuretic peptides: findings from young adults born with very low birth weight","volume":"64","author":"Prickett","year":"2018","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101859_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48553-y","article-title":"Contrasting signals of cardiovascular health among natriuretic peptides in subjects without heart disease","volume":"9","author":"Prickett","year":"2019","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.jacadv.2025.101859_bib30","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00125-014-3260-6","article-title":"Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events","volume":"57","author":"Peters","year":"2014","journal-title":"Diabetologia"},{"issue":"7533","key":"10.1016\/j.jacadv.2025.101859_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/bmj.38678.389583.7C","article-title":"Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies","volume":"332","author":"Huxley","year":"2006","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101859_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00380-018-1218-1","article-title":"Association between plasma levels of PCSK9 and the presence of coronary artery disease in Japanese","volume":"34","author":"Nose","year":"2019","journal-title":"Heart Vessels"},{"issue":"1-2","key":"10.1016\/j.jacadv.2025.101859_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cca.2006.12.003","article-title":"Serum lipoprotein lipase mass: clinical significance of its measurement","volume":"378","author":"Kobayashi","year":"2007","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.jacadv.2025.101859_bib34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm.3487","article-title":"MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1","volume":"20","author":"Schober","year":"2014","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101859_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2796.2011.02364.x","article-title":"Plasma CD93 concentration is a potential novel biomarker for coronary artery disease","volume":"270","author":"M\u00e4larstig","year":"2011","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101859_bib36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.atherosclerosis.2010.06.003","article-title":"Circulating lymphotoxin \u03b2 receptor and atherosclerosis: observations from the Dallas heart study","volume":"212","author":"Owens","year":"2010","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101859_bib37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2362.2005.01548.x","article-title":"Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease","volume":"35","author":"Wu","year":"2005","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101859_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084935","article-title":"Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis","volume":"9","author":"Abbas","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jacadv.2025.101859_bib39","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1358863X13508336","article-title":"Soluble TNF and IL-6 receptors: indicators of vascular health in women without cardiovascular disease","volume":"18","author":"Cortez-Cooper","year":"2013","journal-title":"Vasc Med (United Kingdom)"},{"issue":"12","key":"10.1016\/j.jacadv.2025.101859_bib40","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1161\/hq1201.098945","article-title":"Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases","volume":"21","author":"Lee","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101859_bib41","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/ijms20030705","article-title":"The role of osteoprotegerin and its ligands in vascular function","volume":"20","author":"Rochette","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101859_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217926","article-title":"Axl expression is increased in early stages of left ventricular remodeling in an animal model with pressure-overload","volume":"14","author":"Batlle","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jacadv.2025.101859_bib43","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1161\/CIRCULATIONAHA.108.839068","article-title":"Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice","volume":"120","author":"Xiang","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jacadv.2025.101859_bib44","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1002\/eji.200324270","article-title":"Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis","volume":"33","author":"Rodig","year":"2003","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101859_bib45","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/imr.12616","article-title":"Interleukin-18: biological properties and role in disease pathogenesis","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunol Rev"},{"issue":"OCT","key":"10.1016\/j.jacadv.2025.101859_bib46","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3389\/fimmu.2018.02285","article-title":"BAFF and BAFF-receptor in B cell selection and survival","volume":"9","author":"Smulski","year":"2018","journal-title":"Front Immunol"},{"issue":"14","key":"10.1016\/j.jacadv.2025.101859_bib47","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.148208","article-title":"TNFRSF13B polymorphisms counter microbial adaptation to enteric IgA","volume":"6","author":"Platt","year":"2021","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101859_bib48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MOH.0000000000000103","article-title":"The physiological roles of ICAM-1 and ICAM-2 in neutrophil migration into tissues","volume":"22","author":"Lyck","year":"2015","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101859_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4049\/jimmunol.1900868","article-title":"CD13\/Aminopeptidase N is a potential therapeutic target for inflammatory disorders","volume":"204","author":"Lu","year":"2020","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.jacadv.2025.101859_bib50","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1159\/000508255","article-title":"IL-17D: a less studied cytokine of IL-17 family","volume":"181","author":"Liu","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101859_bib51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41569-020-0431-7","article-title":"Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6","volume":"18","author":"Tyrrell","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacadv.2025.101859_bib52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clim.2018.10.017","article-title":"CD84 cell surface signaling molecule: an emerging biomarker and target for cancer and autoimmune disorders","volume":"204","author":"Cuenca","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jacadv.2025.101859_bib53","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3389\/fimmu.2020.02031","article-title":"TLT2 suppresses Th1 response by promoting IL-6 production in monocyte through JAK\/STAT3 signal pathway in tuberculosis","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101859_bib54","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.micinf.2011.10.003","article-title":"XCL1 and XCR1 in the immune system","volume":"14","author":"Lei","year":"2012","journal-title":"Microbes Infect"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101859_bib55","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/ijms19010290","article-title":"Growth hormone (GH) and cardiovascular system","volume":"19","author":"Caicedo","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacadv.2025.101859_bib56","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.atherosclerosis.2018.06.864","article-title":"Protein biomarkers and coronary microvascular dilatation assessed by rubidium-82 PET in women with angina pectoris and no obstructive coronary artery disease","volume":"275","author":"Schroder","year":"2018","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101859_bib57","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/bios8030086","article-title":"C-type natriuretic peptide (CNP) inhibition of interferon-gamma-mediated gene expression in human endothelial cells in vitro","volume":"8","author":"Day","year":"2018","journal-title":"Biosensors (Basel)"},{"key":"10.1016\/j.jacadv.2025.101859_bib58","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.lfs.2018.08.031","article-title":"C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis","volume":"209","author":"Bae","year":"2018","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101859_bib59","doi-asserted-by":"crossref","first-page":"9807","DOI":"10.1038\/s41598-017-10240-1","article-title":"Overexpression of C-type natriuretic peptide in endothelial cells protects against insulin resistance and inflammation during diet-induced obesity","volume":"7","author":"Bae","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacadv.2025.101859_bib60","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12931-016-0335-6","article-title":"C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice","volume":"17","author":"Kimura","year":"2016","journal-title":"Respir Res"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25002790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25002790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T02:16:54Z","timestamp":1774577814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X25002790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2772963X25002790"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.101859","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro-C-Type Natriuretic Peptide in Women With Angina Pectoris and No Obstructive Coronary Artery Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.101859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101859"}}